Medobeta

Betamethasone, the active ingredient in Medobeta, is a corticosteroid (glucocorticoid) presented as a topical formulation for cutaneous use. It reduces inflammation and immune responses in various skin disorders. GNH USA supplies Medobeta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Betamethasone is a glucocorticoid used to manage inflammatory and immune‑mediated skin disorders.

- Eczema: alleviates redness, itching and swelling associated with the condition. - Dermatitis: suppresses inflammatory pathways to improve skin integrity. - Psoriasis: reduces plaque formation and scaling. - Allergic skin reactions: limits hypersensitivity‑driven inflammation. - Other inflammatory skin conditions: provides symptomatic relief where topical steroids are indicated.

Topical Betamethasone may cause local and systemic adverse reactions.

Common Side Effects: - Burning or stinging at the application site - Skin dryness or peeling - Itching or mild erythema - Folliculitis or acneiform eruptions - Hypertrichosis (excess hair growth) - Contact dermatitis

Serious or Rare Side Effects: - Skin atrophy or thinning - Telangiectasia (visible small blood vessels) - Hypopigmentation or depigmentation - Secondary bacterial, fungal or viral skin infection - Systemic absorption leading to adrenal suppression - Allergic reaction with severe rash or swelling

When using Medobeta, consider the following safety measures.

- Avoid use on infected or ulcerated skin: may worsen infection. - Limit application area and duration: prolonged use on large areas can increase systemic exposure. - Use lowest effective potency: reduces risk of skin atrophy. - Consult a healthcare professional before use in children: pediatric skin is more susceptible. - Do not apply occlusive dressings unless directed: can enhance absorption. - Store at room temperature: keep in the original container, protect from moisture and light.

Betamethasone may interact with other medications that affect steroid metabolism or immune function.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and HPA‑axis suppression. - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase systemic exposure. - Live vaccines: reduced vaccine efficacy and increased infection risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of skin irritation. - Antihistamines: potential additive sedative effect if systemic absorption occurs. - Other topical agents (e.g., retinoids, salicylic acid): may enhance irritation or alter absorption.